{"date":"2026-05-18","count":37,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7427-2026-05-18-2250-1jb8ii5","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"22:50:09","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-05-18 22:50，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-05-18-1920-13ugslm","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"19:20:55","subject":"公告本公司董事會決議召開115年股東常會(增列報告事項)。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-05-18 19:20，「公告本公司董事會決議召開115年股東常會(增列報告事項)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-18-1919-1mlebku","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"19:19:29","subject":"更正115年3月背書保證資訊揭露明細表","clause":"第53款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-18 19:19，「更正115年3月背書保證資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-05-18-1901-5rax5d","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"19:01:09","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-05-18 19:01，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-05-18-1729-b0o4qc","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-05-18","time":"17:29:06","subject":"公告本公司股票初次創新板上市前現金增資收足股款暨現金增資基準日","clause":"第44款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-05-18 17:29，「公告本公司股票初次創新板上市前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-05-18-1728-18o7y","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"17:28:07","subject":"公告本公司董事會通過115年第1季財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-05-18 17:28，「公告本公司董事會通過115年第1季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-05-18-1723-97t2jy","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"17:23:22","subject":"本公司董事會決議部分放棄對子公司「牧騰生物科技股份有限公司」之現金增資普通股新股之認購權","clause":"第44款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-05-18 17:23，「本公司董事會決議部分放棄對子公司「牧騰生物科技股份有限公司」之現金增資普通股新股之認購權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-05-18-1721-12tr2p0","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"17:21:00","subject":"代重要子公司「牧騰生物科技股份有限公司」公告辦理現金增資發行新股事宜","clause":"第9款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-05-18 17:21，「代重要子公司「牧騰生物科技股份有限公司」公告辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-05-18-1718-7ow0nm","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"17:18:44","subject":"代子公司瑞亞生醫(股)公司公告董事會決議114年度不發放股利","clause":"第14款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-05-18 17:18，「代子公司瑞亞生醫(股)公司公告董事會決議114年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-18-1707-13gvt25","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-18","time":"17:07:07","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，已通過美國FDA IND30天審查期，將啟動CBL-0302臨床試驗。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-18 17:07，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，已通過美國FD」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-05-18-1623-l0bctx","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"16:23:55","subject":"更正說明本公司115/04/14重大訊息內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-05-18 16:23，「更正說明本公司115/04/14重大訊息內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1614-1tes7vq","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:14:07","subject":"公告本公司第五屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:14，「公告本公司第五屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1613-peusgi","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:13:47","subject":"公告本公司第四屆審計委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:13，「公告本公司第四屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1613-9769qc","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:13:29","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:13，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1613-1udd9xf","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:13:09","subject":"公告本公司新任法人董事指派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:13，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1612-1qbtm4a","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:12:52","subject":"公告本公司115年股東常會決議解除新任董事及及其代表人競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:12，「公告本公司115年股東常會決議解除新任董事及及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1612-3nak6n","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:12:34","subject":"公告本公司115年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:12，「公告本公司115年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-05-18-1612-3il1nf","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:12:01","subject":"公告本公司115年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-05-18 16:12，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-18-1604-fx98nb","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-18","time":"16:04:44","subject":"代重要子公司康儀科技股份有限公司公告單一法人董事代行股東會之重要決議事項","clause":"第15款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-18 16:04，「代重要子公司康儀科技股份有限公司公告單一法人董事代行股東會之重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-05-18-1602-sj3twj","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-05-18","time":"16:02:44","subject":"公告本公司法人董事改派代表人暨三分之一以上董事發生變動","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-05-18 16:02，「公告本公司法人董事改派代表人暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-18-1543-1xeooua","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:43:42","subject":"公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-18 15:43，「公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-05-18-1541-j7dlbs","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:41:13","subject":"公告本公司114年度個體、合併及115年第一季財務報告附表揭露內容","clause":"第53款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-05-18 15:41，「公告本公司114年度個體、合併及115年第一季財務報告附表揭露內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1532-13nqpz5","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:32:19","subject":"公告本公司第五屆審計委員會召集人-更正原任期","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 15:32，「公告本公司第五屆審計委員會召集人-更正原任期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1526-8ahm06","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:26:38","subject":"公告本公司第六屆薪資報酬委員會任期屆滿-更正原任期","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 15:26，「公告本公司第六屆薪資報酬委員會任期屆滿-更正原任期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1526-enxq72","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:26:14","subject":"公告本公司第五屆審計委員會名單-更正原任期","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 15:26，「公告本公司第五屆審計委員會名單-更正原任期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1517-zhkfod","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:17:54","subject":"公告本公司115年股東常會全面改選董事當選名單","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 15:17，「公告本公司115年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-18-1517-qkrt5g","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"15:17:11","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-18 15:17，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1458-1ro4qiv","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:58:56","subject":"公告本公司第一屆永續發展委員會任期屆滿","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:58，「公告本公司第一屆永續發展委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1455-1irfdyf","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:55:34","subject":"公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:55，「公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1449-h1deh7","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:49:00","subject":"公告本公司第六屆薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:49，「公告本公司第六屆薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1448-1agkkdf","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:48:18","subject":"公告本公司第五屆審計委員會名單","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:48，「公告本公司第五屆審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1445-523vu4","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:45:44","subject":"公告本公司第五屆審計委員會召集人","clause":"第6款","fact_date":"2026-05-18","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:45，「公告本公司第五屆審計委員會召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1444-buvjit","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:44:25","subject":"公告本公司董事會推選董事長案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:44，「公告本公司董事會推選董事長案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-18-1436-1jb8ii5","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:36:09","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-18 14:36，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-18-1416-shpnfe","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:16:46","subject":"本公司受邀參加國泰綜合證券舉辦之2026年第二季產業論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-18 14:16，「本公司受邀參加國泰綜合證券舉辦之2026年第二季產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-05-18-1401-okfjlo","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"14:01:51","subject":"本公司受邀參加華南永昌證券舉辦之產業趨勢暨企業論壇","clause":"第12款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-05-18 14:01，「本公司受邀參加華南永昌證券舉辦之產業趨勢暨企業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-05-18-1311-66moi7","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-05-18","time":"13:11:15","subject":"本公司受邀參加櫃檯買賣中心舉辦之業績發表會","clause":"第12款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-05-18 13:11，「本公司受邀參加櫃檯買賣中心舉辦之業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}